Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 2,754 shares at $29.62 ($82K) on 2026-04-23, disclosed to the SEC on 2026-04-24.
Seasonal sale ($82k) by Chief Technology Officer — this insider has traded IMVT in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| IMVT | SELL | 2026-06-26 | $1.5M | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |
| IMVT | SELL | 2026-01-23 | $51K | — | Filing → |